The Centre for Blood Transplant and Cell Therapies (CBTCT) brings together the largest allogeneic stem cell transplant units in Australia with a focus on identifying transplant and cell therapy strategies to reduce graft versus host disease and improve patient and disease outcomes after transplant. In this webinar series, investigators from the CBTCT will review major topics in stem cell transplantation and cell therapy, highlighting how the activities of the CBTCT are addressing current challenges in stem cell transplantation. The fourth webinar of this series addresses developments in the field of cellular therapy in the management of two common post-allogeneic bone marrow transplant complications. Professor David Gottlieb will highlight the role of cell therapies in the treatment of opportunistic infections in the post-transplant period, while Dr Siok Tey will review novel cellular therapies for the treatment of graft vs host disease

Speakers:

Professor David Gottlieb – Westmead Hospital / University of Sydney

Dr Siok Tey - Royal Brisbane and Womens Hospital / QIMR Berghofer Medical Research Institute

When: Thursday 3 September 2020, 8am AEST

Link to webinar

Link to CBTCT website for all webinar recordings

For more information